Renal transplantation remains the treatment of choice for end-stage renal disease (ESRD) in regard to patient survival. Iran was one of the first countries in the Middle East that began renal transplantation. In a cross-sectional study, we enrolled all cadaveric renal transplant recipients since 2001 until 2007 in Urmia, Iran. 39 cases had criteria to be included in our study by an aim-based sampling. Data about related variables was collected by checklist. Then collected data were entered in SPSS software ver16 and analyzed by Kaplan-Meier test and descriptive statistics. Mean age of graft recipients was 35.18±14.27. 21 patients (53.8%) were male. They developed ESRD because of DM (7 cases=21.2%), HTN (24.2%), Glomerulopathies (36.4%), Polycystic Disease (PKD) (2.6%), and 5 (15.2%) other causes. 4 recipients (10.3%) were hospitalized again because of ATN after transplant. Acute rejection were seen in 7 (17.9%) of recipients. Surgical complications after transplantation included: Urinoma, lymphocele, and surgical site leakage (each in one case). One year patient survival was 89.7% in this study. 4 recipients died within one to 9 months after transplantation. Death-censored one-year graft survival was 100%. Survival rate of cadaveric transplants is in good range. So according to the possibility of transplanting other organs in this method, it’s recommended to make policies to improve cadaveric transplantation.